作者:Laurie B. Schenkel、Erin F. DiMauro、Hanh N. Nguyen、Nagasree Chakka、Bingfan Du、Robert S. Foti、Angel Guzman-Perez、Michael Jarosh、Daniel S. La、Joseph Ligutti、Benjamin C. Milgram、Bryan D. Moyer、Emily A. Peterson、John Roberts、Violeta L. Yu、Matthew M. Weiss
DOI:10.1016/j.bmcl.2017.06.054
日期:2017.8
The NaV1.7 ion channel has garnered considerable attention as a target for the treatment of pain. Herein we detail the discovery and structure-activity relationships of a novel series of biaryl amides. Optimization led to the identification of several state-dependent, potent and metabolically stable inhibitors which demonstrated promising levels of selectivity over NaV1.5 and good rat pharmacokinetics
Na V 1.7离子通道作为治疗疼痛的靶点已引起广泛关注。本文中,我们详细介绍了一系列新型联芳基酰胺的发现与构效关系。优化导致鉴定了几种状态依赖性,有效和代谢稳定的抑制剂,这些抑制剂表现出超过Na V 1.5的有希望的选择性水平和良好的大鼠药代动力学。已证明优先抑制Na V 1.7缓慢失活状态的化合物18进入大鼠福尔马林研究,该药物在达到未结合药物水平时比大鼠Na V 1.7 IC 50高出几倍,因此未能证明其伤害性行为有力降低。